Her2 targeted therapy drugs

Approved HER2-Targeted Drugs. HER2-directed therapy is implemented in the management of nearly all stages of HER2-positive invasive breast

Anti-HER2 therapies (also called HER2 inhibitors or HER2-targeted therapies) are a class of medicines used to treat all stages of HER2-positive breast cancer and certain HER2-low breast cancers.

If a tumor is HER2-positive, the HER2-targeted therapy drug trastuzumab (Herceptin) is included in the chemotherapy regimen. Sometimes other drugs that target HER2 are used. Learn more about trastuzumab and other HER2-targeted therapies for early breast cancer. Learn more about other drug therapies for early breast cancer. Antibody-drug conjugates

You usually have targeted therapy with chemotherapy or hormonal therapy drugs. The type of targeted therapy you have depends on whether the cancer is: HER2

The side effects of HER2 targeted drugs are often mild, but some can be serious. choices of HER2-targeted therapy that treats HER2-positive breast cancer

You usually have targeted therapy with chemotherapy or hormonal therapy drugs. The type of targeted therapy you have depends on whether the cancer is: HER2

All breast cancers are tested for HER2 status to help guide treatment. If a tumor is HER2-positive, the HER2-targeted therapy drug trastuzumab (Herceptin) is included in the chemotherapy regimen. Sometimes other drugs that target HER2 are used. Learn more about trastuzumab and other HER2-targeted therapies for early breast cancer.

HER2-induced breast cancer development and enhances HER2-targeted therapy The synergy scores for multiple drug combinations in HER2

If a tumor is HER2-positive, the HER2-targeted therapy drug trastuzumab (Herceptin) is included in the chemotherapy regimen. Sometimes other drugs that target